chitosan has been researched along with Carcinoma, Hepatocellular in 130 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (10.77) | 29.6817 |
| 2010's | 80 (61.54) | 24.3611 |
| 2020's | 36 (27.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Chen, J; Fang, J; Fang, L; Lv, X; Qi, Y; Sun, R; Tang, Z; Tian, Y; Wang, L; Wang, Y; Zhang, J | 1 |
| Awad, D; Saleh, SR; Shaban, NZ; Shaban, SY; Yehia, SA | 1 |
| Chen, L; Duan, S; Hong, W; Li, Y; Wang, J; Zhu, J | 1 |
| Saravanakumar, K; Sathiyaseelan, A; Wang, MH | 1 |
| Abdulmalek, S; Balbaa, M; El-Kersh, M; Elkady, AI; Gomaa, M; Mostafa, N | 1 |
| A, JM; B, HK; Bharati, S; Kulkarni, SD; Kumar, R; Pai, KSR; Shetty, S; U, A | 1 |
| Han, G; Hao, X; Liu, H; Rong, D; Shi, X; Tang, W; Wang, X; Zhang, C; Zhang, Y; Zheng, Z | 1 |
| Lf Almsaid, H; Muhsin Khalfa, H; Shakir Alkhafaji, R | 1 |
| Aman, RM; Anter, HM; Elamin, KM; Hashim, IIA; Meshali, MM; Othman, DIA | 1 |
| Espinoza, MJC; Kunene, SC; Lin, KS; Lin, YS; Lin, YT; Weng, MT | 1 |
| Lin, Y; Liu, J; Wang, X; Xu, W; Xu, X; Zhang, X; Zheng, Y | 1 |
| Bai, Z; Cui, L; Cui, Y; Li, Z; Lin, K; Liu, Z; Tian, F; Wang, X; Yang, J | 1 |
| Deng, S; Deng, Y; Hu, Y; Huang, J; Jin, H; Liao, Z; Liu, Y; Lovell, JF; Meng, J; Tian, Y; Tuo, Z; Yang, K; Yang, X; Zhou, Z | 1 |
| Ertas, YN; Hamedi, E; Hushmandi, K; Karimi, K; Mohtashamian, S; Mojtabavi, S; Nabavi, N; Nejad, MM; Rabiee, N; Rahmanian, P; Rashidi, M; Rezaee, A; Salimimoghadam, S; Salmani, F; Tehrany, PM; Yousefi, F; Yu, W; Zandieh, MA | 1 |
| Abd El-Hady, BM; Ekram, B; Okasha, H; Rashdan, HRM; Salem, MM | 1 |
| El-Gizawy, SA; Essa, EA; Kira, AY; Nasr, M; Saber, S | 2 |
| Hanafy, NAN; Mahfouz, ME; Moussa, EA; Sheashaa, RF | 1 |
| Albalawi, F; Fakurazi, S; Hussein, MZ; Masarudin, MJ | 1 |
| Chen, C; Chen, G; Chen, Z; Han, L; Huang, X; Wang, F; Yin, S; Zhu, Y | 1 |
| Cheng, JX; Fan, Y; Guo, DY; Huang, M; Liu, J; Sun, J; Zhai, BT; Zhang, XF | 1 |
| Fard, MM; Hassanzadeh, F; Mirian, M; Varshosaz, J | 1 |
| Chen, X; Chi, J; Han, B; Jiang, Z; Liu, W; Peng, Y | 1 |
| Cheng, X; Gao, Y; Hu, S; Jiang, S; Ke, W; Li, M; Song, Z; Sun, P; Wang, G; Wang, Y; Zhang, C; Zhang, W; Zhang, Y; Zheng, QC | 1 |
| Dou, X; He, G; Li, W; Zhang, X | 1 |
| Al-Dhubiab, BE; Attimarad, M; Chavda, V; Jacob, S; Morsy, MA; Nair, AB; Patel, SS; Patel, V; Shah, J; Shinu, P; Sreeharsha, N; Venugopala, KN | 1 |
| Janani, B; Priya, K; Vijayakumar, M | 1 |
| Arafa, K; El-Sherbiny, IM; Emara, M; Hefnawy, A; Khalil, IH | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Ali, HE; Radwan, RR | 1 |
| Abo Mansour, HE; Abo-Elmatty, DM; Badawy, NS; El-Batsh, MM; Mehanna, ET; Mesbah, NM | 2 |
| He, DX; Huang, C; Huang, W; Liu, Y; Long, J; Tan, XW; Tang, S; Wei, H; Xiang, Y; Yu, CY; Zhou, Y | 1 |
| Cheng, J; He, J; Hui, W; Liu, Z; Yan, T; Zhu, S | 1 |
| Chi, J; Han, B; Hou, J; Jiang, Z; Liu, W; Shao, K; Sun, R; Wang, S | 1 |
| Chen, Q; Cheng, Z; Hu, W; Li, X; Xie, Y; Zhong, H; Zhu, H | 1 |
| Chen, YF; Dai, KY; Ji, HY; Liu, AJ; Liu, C; Yu, J | 1 |
| Abulnaja, KO; Al-Malki, AL; Bakkar, A; Barbour, EK; Huwait, EA; Kumosani, TA; Moselhy, SS | 1 |
| Chang, PH; Chao, HM; Chern, E; Hsu, SH; Sekine, K | 1 |
| Shanmugam, A; Shanmugam, V; Subhapradha, N | 1 |
| Guo, B; Ma, PX; Qu, J; Zhao, X | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, GQ | 1 |
| Chen, J; Duan, S; He, J; Hu, Z; Lu, X; Su, J; Yang, N; Zhang, Z; Zhao, Y; Zhou, S | 1 |
| Li, W; Liu, J; Liu, L; Xin, Y; Zhang, E | 1 |
| Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G | 1 |
| Liu, Y; Qiu, N; Xu, B; Zhang, S; Zhao, L; Zhu, H | 1 |
| Chi, J; Han, B; Jiang, Z; Liu, W | 1 |
| Chen, L; Wu, Q; Yang, X; Yu, C; Zhang, J | 1 |
| Badr, Y; El-Sesy, M; Salem, DS; Shouman, SA; Sliem, MA | 1 |
| Chen, ZP; He, JY; Wang, JC; Wu, L | 1 |
| Gan, Y; He, S; Li, J; Liang, J; Miao, Y; Wu, N; Zhang, X | 1 |
| Cao, Y; Chen, L; Diao, E; Gu, Q; Hu, W; Jiang, Y; Li, X; Liu, J; Liu, T; Luo, Y; Sun, F; Wang, Y; Zhang, J; Zhang, L; Zheng, W; Zhou, J | 1 |
| Guo, QY; Li, WJ; Liao, MM; Lin, N; Mao, X; Mi, GJ; Shen, Y; Wang, XY; Webster, TJ; You, C; Zhang, YQ | 1 |
| Abo Gazia, MM; El-Gamal, MM; El-Magd, MA; Elkeiy, MM; Khamis, AA; Zalat, ZA | 1 |
| Ding, Y; Rui, C; Shi, X; Sho, E; Wu, G; Zhan, S | 1 |
| Cui, F; Kawashima, Y; Li, L; Liang, N; Sun, S; Wang, D; Yan, P | 1 |
| Dai, S; Hu, F; Hu, Y; Meng, T; Tan, Y; Wen, L; Yuan, H; Zhao, M | 1 |
| Armenia, E; Barbarisi, A; Barbarisi, M; Caraglia, M; Giudice, A; Masarone, M; Persico, M; Quagliariello, V | 1 |
| Jahanian, A; Raghami, F; Rostami, M; Varshosaz, J | 1 |
| Gao, P; He, DX; Li, ZP; Liu, YF; Ning, Q; Tang, SS; Tang, SY; Wei, H; Ye, PJ; Yu, CY | 1 |
| Jiang, Y; Shi, Y; Su, C; Yu, X; Zhao, L | 1 |
| Chen, H; Li, W; Tao, R; Wang, C; Ye, J; Zhang, C; Zhou, H | 1 |
| Hou, T; Wang, T; Yin, X; Zhang, J; Zhang, N | 1 |
| Balogh, L; Bodnár, M; Borbély, J; Haász, V; Hajdu, I; Jánoki, G; Jánoki, GA; Polyák, A; Pöstényi, Z; Trencsényi, G | 1 |
| Chi, YT; Chow, PK; Chua, QY; Leong, J; Pack, DW; Wang, CH; Xu, Q | 1 |
| Bao, X; Chen, Y; Huang, A; Li, H; Li, S; Niu, J; Ping, Q; Su, Z; Sun, M; Xiao, Y | 1 |
| Gao, J; Liang, W; Shan, W; Wang, W; Zhang, P | 1 |
| Feng, L; Liu, F; Zhang, L; Zhang, N; Zhang, X | 1 |
| Abolafio, G; Cerroni, B; Margheritelli, S; Oddo, L; Paradossi, G; Viganò, L; Villa, R; Zaffaroni, N | 1 |
| Jin, X; Ju, C; Sun, J; Zhang, C; Zi, P | 1 |
| Chen, Y; Du, YZ; Huang, FF; Liu, P; Shi, D; Wang, Y; Yu, RS; Zhu, XL | 1 |
| Chen, H; Cheng, M; Gao, X; Han, J; He, B; Li, Y; Wang, Y; Xu, H; Zhang, Z | 1 |
| Chang, JB; Chen, YL; Chung, JG; Hung, FM; Hung, HF; Lu, HF; Shang, HS; Shih, YL; Wood, WG; Wu, MF; Yeh, C; Yeh, MY | 1 |
| Chu, M; Guo, Y; Liu, H; Otieno, BO; Tan, S; Xu, C; Yang, X; Zhang, Z; Zhao, S | 1 |
| Ding, Y; Jin, X; Mo, R; Zhang, C; Zheng, W | 1 |
| Bánfalvi, G; Bodnár, M; Borbély, J; Emri, M; Hajdu, I; Kollár, J; Márián, T; Sikula, J; Trencsényi, G; Vámosi, G | 1 |
| An, X; Cao, L; Fang, Y; Hu, Q; Li, F; Liang, J; Xin, Z; Yang, W; Zhao, L | 1 |
| Han, L; Tang, C; Yin, C | 1 |
| Deng, H; Huang, R; Jin, H; Liu, X; Luo, W; Shi, X; Zhang, Q; Zhou, X | 1 |
| Kazem, A; Nafee, N; Nasr, M; Saad, H | 1 |
| Dong, X; Leng, XG; Liu, L; Song, L; Zhang, H; Zhu, D | 1 |
| Jiang, B; Liu, F; Song, M; Wan, J; Yang, C; Zhou, D; Zhu, R | 1 |
| Dai, LC; Huang, HL; Li, J; Li, LQ; Niu, PP; Qian, FC; Zhong, J | 1 |
| Chang, JB; Chou, J; Chung, JG; Hung, HF; Kuo, WL; Lu, HF; Shang, HS; Wu, LY; Yeh, C; Yeh, MY | 1 |
| Han, B; Jiang, Z; Li, H; Li, X; Liu, W; Yang, Y | 1 |
| Benzoni, I; Berkó, S; Budai-Szűcs, M; Csányi, E; Dionigi, P; Gavini, E; Giunchedi, P; Maestri, M; Porcu, EP; Rassu, G; Salis, A | 1 |
| He, J; Lai, C; Lu, X; Luo, G; Peng, Y; Xie, X; Xie, Y; Yu, X; Zhao, Y; Zhou, N; Zhou, S; Zhuo, H | 1 |
| Han, B; Jiang, Z; Li, H; Liu, W; Yang, Y | 1 |
| Chen, Q; Han, B; Hu, R; Jiang, Z; Song, F; Wang, H; Yang, Y | 1 |
| Chang, JS; Chang, KL; Kong, ZL; Kuo, HP | 1 |
| Jin, Y; Liu, Y; Ren, J; Yu, J; Zhang, L; Zhao, J | 1 |
| Feng, Y; Guo, YB; Li, P; Liu, YF; Mao, QS; Wang, F; Wang, L; Wang, ZW; Xue, WJ; Yang, YM | 1 |
| Jiang, Y; Meng, X; Qi, X; Wu, Z | 1 |
| Dong, X; Duan, M; Leng, X; Liu, L; Liu, Q; Wang, H; Zhu, D; Zhu, Y | 1 |
| Duan, S; Fang, Y; He, J; Huang, X; Lai, C; Lu, X; Luo, G; Song, M; Xie, Y; Yi, P; Yu, X; Zhang, Z; Zhao, J; Zhao, Y; Zhou, N; Zhou, S | 1 |
| Chen, F; Chen, Y; Cheng, B; Feng, M; Wang, G; Wang, S; Wang, Y; Xiong, B; Zhang, C | 1 |
| Chang, R; Chen, Z; Hu, B; Qiang, Y; Wang, D; Wang, G | 1 |
| Bai, MY; Hong, PD; Tang, SL; Wang, JY | 1 |
| Gao, P; He, DX; Huang, C; Huang, W; Li, NM; Li, ZP; Ning, Q; Tan, XW; Xiang, L; Yang, S; Ye, PJ; Yu, CY | 1 |
| Hong, SC; Kim, H; Lee, J; Yoo, SY | 1 |
| Feng, Q; Huang, Z; Jin, C; She, Z; Xu, Y; Zhang, B | 1 |
| Li, YP; Lu, Y; Tao, L; Wang, W; Wang, Y; Yao, J; Zhou, JP | 1 |
| Choi, HJ; Kim, E; Kim, JH; Lee, JD; Lee, JT; Moon, YM; Park, K; Park, KB; Sohn, JH; Yoo, NC | 1 |
| Bei, YY; Hu, W; Hu, ZH; Wang, Q; Wang, WJ; Xu, JY; Zhang, L; Zhang, Q; Zhang, XN | 1 |
| Wen, Z; Xu, Y; Xu, Z | 1 |
| Baek, KH; Choi, JJ; Han, SE; Huh, JH; Kim, JS; Kim, K; Kim, MS; Kwon, IC; Lee, HY; Noh, SM; Oh, YK; Park, MO; Shim, G | 1 |
| Jain, NK; Jain, SK | 1 |
| Chen, X; Li, X; Li, Z; Liu, X; Qian, Z; Wei, Y; Yi, T; Zhao, X; Zhong, Q; Zhou, L; Zhou, S | 1 |
| Chen, W; Chen, Y; Deng, X; Duan, J; Han, S; Huang, B; Li, B; Liao, M; Zhang, Y; Zhao, J | 1 |
| Alonso, MJ; D'Angelo, I; Garcia-Fuentes, M; Parajó, Y; Welle, A | 1 |
| Duan, C; Feng, F; Jia, L; Liu, Y; Tian, K; Wang, F; Wang, Y; Zhang, D; Zhang, Q; Zheng, D | 1 |
| Duan, C; Gao, J; Jia, L; Liu, G; Liu, Y; Tian, X; Wang, F; Zhang, D; Zhang, Q; Zheng, D | 1 |
| Cai, LL; Chen, FY; Du, YZ; Hu, FQ; Huang, X; Li, X; Liu, P; Ye, YQ; Yuan, H | 1 |
| Bei, YY; Guan, M; Liu, Y; Zhang, Q; Zhang, XN; Zhou, Y; Zhu, QL | 1 |
| Shi, L; Tang, C; Yin, C | 1 |
| Gao, JQ; Han, M; Hu, YL; Li, N; Qiu, F; Tabata, Y; Tang, GP; Zhao, QQ; Zhou, Y | 1 |
| Chen, H; Cheng, M; Han, J; He, B; Li, Q; Liu, Z; Wan, T; Wang, W; Xu, H; Yang, F; Ye, T; Zha, B | 1 |
| Cai, LL; Du, YZ; Hu, FQ; Liu, P; You, J; Yuan, H | 1 |
| Chen, J; Dong, L; Gao, F; Huang, Z; Zhang, J; Zhang, Z | 1 |
| Chen, HX; Cheng, MR; Han, J; He, B; Li, Q; Wan, T; Wang, W; Xu, HZ; Yang, FX; Ye, T; Zha, BB | 1 |
| Cho, CS; Choi, YJ; Kim, TH; Nah, JW; Park, IK | 1 |
| Ahn, WS; Choi, SH; Choi, WJ; Chun, SK; Kim, A; Kim, CK; Kim, JK; Lee, MK; Oungbho, K; Park, JS | 1 |
| Ahn, JB; Cho, BC; Choi, HJ; Chung, HC; Kim, EH; Kim, JH; Lee, JD; Lee, JT; Roh, JK; Sohn, JH; Yoo, NC | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, JK; Lee, JD; Lee, JT; Lee, KS; Moon, YM; Paik, YH | 1 |
| Chen, M; Qi, L; Xu, Z | 1 |
| Cui, YJ; Du, YM; Gong, LL; Li, Y; Shi, XW; Wang, Y; Yang, GF; Yuan, HY; Zheng, F | 1 |
| Chen, CA; Chou, PH; Kung, SS; Sun, YM; Yu, BY | 1 |
| Kakimoto, S; Kano, H; Nagasaki, T; Nakatani, M; Satoh, T; Shinkai, S | 1 |
| Gou, XJ; Hou, SX; Yao, Q; You, JZ; Zhang, X; Zhao, G | 1 |
| Anzai, N; Hayatsu, H; Nakandakari, N; Negishi, K; Negishi, T; Sugiyama, C; Taniyama, T | 1 |
3 review(s) available for chitosan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application.
Topics: Carcinoma, Hepatocellular; Chitosan; Humans; Liver Neoplasms; Nanoparticles; Precision Medicine | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Liver Neoplasms | 2017 |
3 trial(s) available for chitosan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Chitosan; Dose-Response Relationship, Drug; Drug Administration Routes; Holmium; Humans; Liver Function Tests; Models, Theoretical; Patient Selection; Radioisotopes; Radiotherapy Dosage; Survival Rate; Young Adult | 2009 |
Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chitosan; Female; Holmium; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radioisotopes; Survival Rate; Treatment Outcome | 2006 |
125 other study(ies) available for chitosan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Topics: Animals; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Movement; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Random Allocation; Spectroscopy, Fourier Transform Infrared; Xenograft Model Antitumor Assays | 2021 |
A Titanium (IV)-Dithiophenolate Complex and Its Chitosan Nanocomposite: Their Roles towards Rat Liver Injuries In Vivo and against Human Liver Cancer Cell Lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbon Tetrachloride; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Chitosan; Hep G2 Cells; Humans; Liver Neoplasms; Male; Nanocomposites; Oxidative Stress; Phenols; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Titanium | 2021 |
Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Graphite; Humans; Liver Neoplasms; Magnetic Phenomena; Mice; Nanoparticles; Quantum Dots | 2022 |
Cerium oxide decorated 5-fluorouracil loaded chitosan nanoparticles for treatment of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cerium; Chitosan; Fibroblasts; Fluorouracil; Liver Neoplasms; Mammals; Mice; Nanoparticles; NIH 3T3 Cells; Reactive Oxygen Species | 2022 |
Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
Topics: Animals; Bee Venoms; Carcinoma, Hepatocellular; Chitosan; ErbB Receptors; Liver Neoplasms; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Nanoparticles; Peptides | 2022 |
Anticancer therapeutic potential of phosphorylated galactosylated chitosan against N-nitrosodiethyl amine-induced hepatocarcinogenesis.
Topics: Amines; Animals; Carcinoma, Hepatocellular; Chitosan; Liver Neoplasms; Mice; Spectroscopy, Fourier Transform Infrared | 2022 |
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ.
Topics: 14-3-3 Proteins; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Phenylurea Compounds; Protein Serine-Threonine Kinases; Quinolines; RNA, Circular; RNA, Untranslated; Transcription Factors | 2022 |
Rat Hepatocellular Primary Cells: A Cellular and Genetic Assessment of the Chitosan Nanoparticles-Induced Damage and Cytotoxicity.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Liver Neoplasms; Nanoparticles; Particle Size; Rats | 2022 |
Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy.
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Nanomedicine; Nanoparticles; Oxidoreductases; Particle Size; Prospective Studies | 2023 |
Synthesis and characterization of silica nanoparticles from rice ashes coated with chitosan/cancer cell membrane for hepatocellular cancer treatment.
Topics: Animals; Carcinoma, Hepatocellular; Cell Membrane; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Hydrogen-Ion Concentration; Liver Neoplasms; Mice; Mice, Nude; Nanoparticles; Oryza; Silicon Dioxide | 2023 |
Hepatoma-targeting and reactive oxygen species-responsive chitosan-based polymeric micelles for delivery of celastrol.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Micelles; Polymers; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery.
Topics: Carcinoma, Hepatocellular; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Glycyrrhetinic Acid; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Metal-Organic Frameworks; Nanoparticles; Tumor Microenvironment | 2023 |
Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma.
Topics: Ascites; Carcinoma, Hepatocellular; Chitosan; Dextrans; Ferroptosis; Humans; Hydrogels; Immunotherapy; Liver Neoplasms; Sulfasalazine | 2023 |
Investigation of novel HCV therapies: Boscia angustifalia & Boscia senegalensis extracts loaded on galactosylated chitosan nanoparticles synthesized by eco-friendly method for HCV treatment.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chitosan; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Nanoparticles | 2023 |
Telmisartan-Loaded Lactosylated Chitosan Nanoparticles as a Liver Specific Delivery System: Synthesis, Optimization and Targeting Efficiency.
Topics: Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Lactose; Liver Neoplasms; Nanoparticles; Particle Size; Telmisartan | 2023 |
Potential of curcumin and niacin-loaded targeted chitosan coated liposomes to activate autophagy in hepatocellular carcinoma cells: An in vitro evaluation in HePG2 cell line.
Topics: Autophagy; Carcinoma, Hepatocellular; Chitosan; Curcumin; Drug Carriers; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Nanoparticles; Niacin; Particle Size | 2023 |
Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Sorafenib | 2023 |
Preparation of a modified silk-based gel/microsphere composite as a potential hepatic arterial embolization agent.
Topics: Alginates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chitosan; Gels; Hepatic Artery; Humans; Liver Neoplasms; Microspheres | 2023 |
Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Diethylnitrosamine; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Mice; Nanoparticles; Telmisartan; Tissue Distribution; Vascular Endothelial Growth Factor A | 2023 |
Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chitosan; Curcumin; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Particle Size | 2023 |
Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cathepsin B; Chitosan; Chondroitin; Drug Liberation; Drug Therapy, Combination; Fluorouracil; Hep G2 Cells; Humans; Hyaluronic Acid; Liver Neoplasms; Mice; Molecular Targeted Therapy; Nanocapsules; NIH 3T3 Cells; Nitroquinolines; Protease Inhibitors | 2020 |
Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Mice | 2019 |
Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
Topics: Animals; Biocompatible Materials; Carcinoma, Hepatocellular; Chitosan; Galactose; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Nanoparticles; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
Astaxanthin Encapsulated in Biodegradable Calcium Alginate Microspheres for the Treatment of Hepatocellular Carcinoma In Vitro.
Topics: Alginates; Capsules; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Chitosan; Drug Liberation; Hep G2 Cells; Humans; Liver Neoplasms; Microspheres; Particle Size; Reactive Oxygen Species; Xanthophylls | 2020 |
Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma.
Topics: 2-Acetylaminofluorene; Animals; Antimetabolites, Antineoplastic; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Chitosan; Deoxycytidine; Gemcitabine; Liver Neoplasms; Male; Nanoparticles; Rats; Xenograft Model Antitumor Assays | 2019 |
Chitosan-mediated synthesis of biogenic silver nanoparticles (AgNPs), nanoparticle characterisation and in vitro assessment of anticancer activity in human hepatocellular carcinoma HepG2 cells.
Topics: Anti-Bacterial Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Chitosan; DNA Fragmentation; Hep G2 Cells; Humans; Liver Neoplasms; Metal Nanoparticles; Silver; Spectrum Analysis | 2020 |
Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Nanoparticles; Rats, Wistar | 2020 |
Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma.
Topics: Acrylates; Animals; Carcinoma, Hepatocellular; Chitosan; Liver Neoplasms; Nanogels; Polyethylene Glycols; Polyethyleneimine; Rats; Rutin; Spectroscopy, Fourier Transform Infrared | 2021 |
Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Diethylnitrosamine; Doxorubicin; Drug Combinations; Drug Delivery Systems; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Malondialdehyde; Mice; Myocardium; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Verapamil | 2020 |
Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chitosan; Fluorouracil; Folic Acid; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Ligands; Liver Neoplasms; Nanoparticles; Precision Medicine; Prodrugs; Solubility | 2020 |
Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice.
Topics: Animals; Carcinoma, Hepatocellular; Cardiotoxicity; Chitosan; Doxorubicin; Liver Neoplasms; Male; Mice; Nanoparticles; Plant Extracts; Vascular Endothelial Growth Factor A; Zingiber officinale | 2021 |
Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Combined Modality Therapy; Doxorubicin; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Polymers; Prodrugs; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Effects of carboxymethyl chitosan oligosaccharide on regulating immunologic function and inhibiting tumor growth.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Female; Humans; Liver; Liver Neoplasms; Macrophages, Peritoneal; Male; Mice; Oligosaccharides; Phagocytosis | 2020 |
Alginate-azo/chitosan nanocapsules in vitro drug delivery for hepatic carcinoma cells: UV-stimulated decomposition and drug release based on trans-to-cis isomerization.
Topics: Alginates; Carcinoma, Hepatocellular; Chitosan; Doxorubicin; Hep G2 Cells; Humans; Isomerism; Liver Neoplasms; Nanocapsules; Ultraviolet Rays | 2021 |
The immunosuppressive effects of low molecular weight chitosan on thymopentin-activated mice bearing H22 solid tumors.
Topics: Animals; Blood Cell Count; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Cytokines; Female; Liver Neoplasms; Mice; Mice, Inbred BALB C; Molecular Weight; T-Lymphocytes; Thymopentin | 2021 |
Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chitosan; Chromatography, Liquid; Down-Regulation; Hep G2 Cells; Humans; Inhibitory Concentration 50; Lactones; Liver Neoplasms; Metabolomics; Nanoparticles; Particle Size; Serum Albumin, Human; Tandem Mass Spectrometry; Up-Regulation | 2021 |
Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
Topics: Anticholesteremic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Liver Neoplasms; Neoplastic Stem Cells; Tumor Cells, Cultured; Wnt Signaling Pathway | 2017 |
Chitosan nanoparticles from marine squid protect liver cells against N-diethylnitrosoamine-induced hepatocellular carcinoma.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Chitosan; Decapodiformes; Diethylnitrosamine; Lipid Peroxidation; Liver; Liver Neoplasms; Nanoparticles; Rats; Rats, Wistar | 2017 |
pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Topics: Carcinoma, Hepatocellular; Chitosan; Delayed-Action Preparations; Doxorubicin; Esters; Hep G2 Cells; Humans; Hydrogels; Hydrogen-Ion Concentration; Liver Neoplasms | 2017 |
Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
Topics: Antibiotics, Antineoplastic; Bromelains; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Liver Neoplasms; Nanoparticles; Neoplasms | 2017 |
Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Chemokine CXCL10; Chitosan; Dendritic Cells; Disease Models, Animal; Drug Carriers; Folic Acid; Heterografts; Mice; Mice, Inbred C57BL; Nanoparticles; Treatment Outcome; Vaccines, DNA | 2017 |
INHIBITORY EFFECT OF CHITOSAN OLIGOSACCHARIDE ON HUMAN HEPATOMA CELLS
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Humans; Liver Neoplasms; Oligosaccharides | 2017 |
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid | 2017 |
On the hypoxic tumor targeting ability of two chitosan micelles loaded with oil-soluble CdSe quantum dots.
Topics: Antineoplastic Agents; Cadmium Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; HeLa Cells; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Micelles; Oils; Polyethylene Glycols; Quantum Dots; Selenium Compounds; Uterine Cervical Neoplasms | 2018 |
Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Liver Neoplasms, Experimental; Mice; Xenograft Model Antitumor Assays | 2017 |
Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Carcinoma, Hepatocellular; Cells, Cultured; Chitosan; Down-Regulation; Hepatocyte Nuclear Factor 1-alpha; Humans; Lipid Droplets; Liver Neoplasms; Male; Mice; Oligosaccharides; PCSK9 Inhibitors; Proprotein Convertase 9; Receptors, LDL; RNA, Small Interfering; Sterol Regulatory Element Binding Protein 2 | 2018 |
Improved chemo-photothermal therapy of hepatocellular carcinoma using chitosan-coated gold nanoparticles.
Topics: Carcinoma, Hepatocellular; Cell Survival; Chitosan; Chromatography, High Pressure Liquid; Combined Modality Therapy; Gold; Hep G2 Cells; Humans; Liver Neoplasms; Metal Nanoparticles; Microscopy, Electron, Transmission; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2018 |
[Anti-tumor effect of brucine-loaded chitosan nanoparticles in vitro].
Topics: Apoptosis; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Nanoparticles; Polymers; Strychnine | 2016 |
Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Exosomes; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; MicroRNAs; Nanoparticles; Phosphotransferases (Alcohol Group Acceptor); RNA Interference; RNA, Small Interfering; RNAi Therapeutics | 2018 |
Enhanced cytotoxic and apoptotic potential in hepatic carcinoma cells of chitosan nanoparticles loaded with ginsenoside compound K.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Deoxycholic Acid; Drug Carriers; Drug Liberation; Ginsenosides; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles | 2018 |
Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Diterpenes; Epoxy Compounds; Galactose; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Nanoparticles; Phenanthrenes; Reproduction; Signal Transduction; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Chitosan nanoparticles from Artemia salina inhibit progression of hepatocellular carcinoma in vitro and in vivo.
Topics: Animals; Apoptosis; Artemia; Carcinoma, Hepatocellular; Chitosan; Hep G2 Cells; Liver Neoplasms; Nanoparticles; Rats | 2020 |
Microporous cellulosic scaffold as a spheroid culture system modulates chemotherapeutic responses and stemness in hepatocellular carcinoma.
Topics: AC133 Antigen; Antineoplastic Agents; Cadherins; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Hyaluronan Receptors; Liver Neoplasms; Neoplastic Stem Cells; Octamer Transcription Factor-3; Spheroids, Cellular | 2019 |
Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Deoxycholic Acid; Drug Carriers; Female; Folic Acid; Humans; Injections, Intravenous; Liver Neoplasms; MCF-7 Cells; Mice; Micelles; Neoplasm Transplantation; Paclitaxel; Particle Size; Xenograft Model Antitumor Assays | 2018 |
Redox-responsive polymer inhibits macrophages uptake for effective intracellular gene delivery and enhanced cancer therapy.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chitosan; Drug Carriers; Female; Gene Transfer Techniques; Glutathione; Glycolipids; Humans; Liver Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Oxidation-Reduction; Polymers; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Butyric Acid; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Cytokines; Drug Carriers; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms | 2019 |
PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Membrane Permeability; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Emulsions; Hep G2 Cells; Humans; Liver Neoplasms; Nanocapsules; Octreotide; Polyethylene Glycols; Sorafenib; Surface Properties | 2019 |
Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.
Topics: ADAM17 Protein; Animals; Apoptosis; Biocompatible Materials; Carcinoma, Hepatocellular; Cell Line; Chitosan; Down-Regulation; Drug Carriers; Drug Synergism; Fluorouracil; Hemolysis; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; MicroRNAs; Nanoparticles; Prodrugs | 2019 |
Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Nanoparticles; Reactive Oxygen Species | 2019 |
Characterization, Cytotoxicity and Genotoxicity of Graphene Oxide and Folate Coupled Chitosan Nanocomposites Loading Polyprenol and Fullerene Based Nanoemulsion Against MHCC97H Cells.
Topics: Carcinoma, Hepatocellular; Chitosan; Folic Acid; Fullerenes; Graphite; Humans; Liver Neoplasms; Nanocomposites; Oxides | 2019 |
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Topics: Animals; Benzamides; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Humans; Immunotherapy; Liver Neoplasms; Macrophages; Mannose; Mice; Microscopy, Confocal; Nanoparticles; Protein Kinase Inhibitors; RAW 264.7 Cells; Sorafenib; Tissue Distribution | 2019 |
(99m)Tc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Folate Receptors, GPI-Anchored; Liver Neoplasms; Male; Nanoparticles; Particle Size; Radiopharmaceuticals; Rats; Rats, Inbred F344; Sodium Pertechnetate Tc 99m; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Caspase 3; Cell Death; Cell Survival; Chitosan; Combined Modality Therapy; DNA; Doxorubicin; Fluorescent Antibody Technique; Genetic Therapy; Hep G2 Cells; Humans; Liver Neoplasms; Luciferases; Microspheres; Nanoparticles; Tumor Suppressor Protein p53 | 2013 |
Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Mice; Nanoparticles; Octreotide; Particle Size; Polyethylene Glycols; Polymers; Tissue Distribution | 2013 |
A novel chitosan-based thermosensitive hydrogel containing doxorubicin liposomes for topical cancer therapy.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Cyclohexenes; Doxorubicin; Glycerophosphates; Hydrogels; Liposomes; Liver Neoplasms; Mice; Temperature | 2013 |
Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Chitosan; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Stability; Female; Hep G2 Cells; Humans; Liver Neoplasms; Maximum Tolerated Dose; Melanoma, Experimental; Mice; Nanoparticles; Particle Size; Survival Rate; Taxoids; Time Factors | 2013 |
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Chitosan; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Microbubbles; Molecular Structure; Polymers; Structure-Activity Relationship | 2013 |
Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Liver; Liver Neoplasms; Male; Mice; Micelles; Paclitaxel; Poloxamer; Rheology; Temperature | 2013 |
Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.
Topics: Adenosine Triphosphate; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles | 2013 |
Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Fluorouracil; Glycyrrhetinic Acid; Humans; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size | 2013 |
Effects of chitosan on xenograft models of melanoma in C57BL/6 mice and hepatoma formation in SCID mice.
Topics: Animals; Carcinoma, Hepatocellular; Chelating Agents; Chitosan; Heterografts; Liver Neoplasms; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Survival Rate; Tumor Burden; Tumor Cells, Cultured | 2013 |
Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Polymers; Tissue Distribution; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2014 |
Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Male; Membrane Fluidity; Mice; Mice, Inbred ICR; Micelles; Paclitaxel; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Tumor-specific localization of self-assembled nanoparticle PET/MR modalities.
Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Contrast Media; Flow Cytometry; Folate Receptors, GPI-Anchored; Folic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Male; Nanoparticles; Polyglutamic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2014 |
Cytotoxicity and apoptotic effects of tea polyphenol-loaded chitosan nanoparticles on human hepatoma HepG2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Nucleus; Chitosan; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles; Particle Size; Polyphenols; Tea | 2014 |
Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Female; Galactose; Genetic Therapy; Humans; Inhibitor of Apoptosis Proteins; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; RNA Interference; RNA, Small Interfering; Survivin; Vascular Endothelial Growth Factor A | 2014 |
Nanofibrous mats layer-by-layer assembled by HTCC/layered silicate composites with in vitro antitumor activity against SMMC-7721 cells.
Topics: Aluminum Silicates; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Drug Evaluation, Preclinical; Humans; Liver Neoplasms; Minerals; Nanocomposites; Nanofibers; Polymerization; Quaternary Ammonium Compounds; Silicates | 2014 |
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53 | 2014 |
TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; DNA; Gene Products, tat; Genetic Therapy; Gonadotropin-Releasing Hormone; Humans; Molecular Weight; Nanocapsules; Nanoconjugates; Treatment Outcome | 2014 |
Biological effects of irradiating hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2'-deoxyuridine-chitosan drug loading nanoparticles.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Chitosan; DNA Damage; DNA Repair; Hep G2 Cells; Humans; Idoxuridine; Iodine Radioisotopes; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Nanoparticles; Rabbits; Radiopharmaceuticals | 2014 |
Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Transfer Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Midkine; Nanoparticles; Nerve Growth Factors; Nucleic Acid Conformation; RNA Interference; RNA, Small Interfering; Surface Properties; Transfection | 2015 |
Chitosan oligosaccharides in combination with Agaricus blazei Murill extract reduces hepatoma formation in mice with severe combined immunodeficiency.
Topics: Agaricus; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chitosan; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Mice, SCID; Oligosaccharides; Plant Extracts; Severe Combined Immunodeficiency; Vascular Endothelial Growth Factor A | 2015 |
Preparation and anti-tumor metastasis of carboxymethyl chitosan.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Chitosan; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 9; Mice; Vascular Endothelial Growth Factor A | 2015 |
Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study.
Topics: Absorbable Implants; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cattle; Chemistry, Pharmaceutical; Chitosan; Coloring Agents; Diagnostic Imaging; Drug Delivery Systems; Drug Implants; Gels; Glycerophosphates; Indocyanine Green; Injections, Intra-Arterial; Liver Neoplasms; Pharmaceutical Solutions; Temperature; Viscosity | 2015 |
Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chemokine CXCL10; Chitosan; Cricetinae; DNA; Female; Folic Acid; Immunotherapy; Interferon gamma Receptor; Liver Neoplasms; Mice; Mice, Inbred BALB C; Nanocapsules; Particle Size; Receptors, Interferon; Transfection; Treatment Outcome | 2014 |
Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo.
Topics: Animals; Antigens, CD34; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Chitosan; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Interferon-gamma; Liver Neoplasms; Mice; Neovascularization, Pathologic; Spectrophotometry, Infrared; Spleen; Thymus Gland; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2015 |
Antitumor and antimetastasis effects of macerating solutions from an injectable chitosan-based hydrogel on hepatocarcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections; Interleukin-2; Liver; Liver Neoplasms; Male; Mice; Neoplasm Metastasis; Tumor Necrosis Factor-alpha | 2015 |
Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata.
Topics: Agaricales; Antineoplastic Agents; Antrodia; Apoptosis; Biological Factors; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Chitosan; DNA Fragmentation; fas Receptor; G1 Phase; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Nanoparticles; Polysaccharides; Reactive Oxygen Species; Taiwan | 2015 |
Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Linoleic Acid; Liver Neoplasms; Male; Mice; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Particle Size | 2015 |
Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma.
Topics: Animals; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Gene Transfer Techniques; Genetic Therapy; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Suppressor Proteins | 2016 |
Modified chitosan thermosensitive hydrogel enables sustained and efficient anti-tumor therapy via intratumoral injection.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Drug Liberation; Glutaral; Hydrogels; Injections, Intralesional; Liver Neoplasms; Male; Mechanical Phenomena; Mice; Paclitaxel; Polyvinyl Alcohol; Rheology; Temperature | 2016 |
Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; DNA; Gene Products, tat; Gene Transfer Techniques; Gonadotropin-Releasing Hormone; Liver; Liver Neoplasms; Male; Mice; Mice, Nude; Nanoparticles; Tissue Distribution | 2016 |
Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Chemokine CXCL10; Chitosan; Coated Materials, Biocompatible; Folate Receptors, GPI-Anchored; Folic Acid; Immunotherapy, Adoptive; Mice; Mice, Inbred BALB C; Mice, Nude; Nanocapsules; Survival Rate; T-Lymphocytes, Cytotoxic; Treatment Outcome | 2016 |
Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.
Topics: Aptamers, Nucleotide; Carcinoma, Hepatocellular; Cell Adhesion; Cell Separation; Chitosan; Durapatite; Humans; Liver Neoplasms; Nanostructures; Neoplastic Cells, Circulating; Surface Properties | 2016 |
Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; Chitosan; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA, Small Interfering; RNAi Therapeutics | 2017 |
Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Chondroitin Sulfates; Doxorubicin; Drug Carriers; Female; Ferric Compounds; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microspheres; Neoplasm Transplantation; Particle Size; Polysaccharides; Spectrophotometry | 2017 |
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
Topics: A549 Cells; Absorption, Physiological; Animals; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Fluorouracil; Glycosylation; Half-Life; Hemolysis; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Mice; Nanoparticles; Prodrugs; Rabbits; Random Allocation; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
Silk fibroin/chitosan scaffold: preparation, characterization, and culture with HepG2 cell.
Topics: Biocompatible Materials; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Compressive Strength; Fibroins; Formazans; Humans; Liver Neoplasms; Materials Testing; Porosity; Silk; Tetrazolium Salts; Tissue Engineering; Tissue Scaffolds; X-Ray Diffraction | 2008 |
Urocanic acid-modified chitosan-mediated p53 gene delivery inducing apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its antitumor effect in vitro and in vivo.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Genetic Therapy; Humans; Liver Neoplasms; Transfection; Tumor Suppressor Protein p53; Urocanic Acid | 2008 |
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Galactose; Liver Neoplasms; Mice; Nanoparticles | 2010 |
Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chelating Agents; Chitosan; Female; Humans; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Mice; Mice, Nude; Nanoparticles; Necrosis; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2009 |
Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.
Topics: Animals; Arginine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Hemolysis; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Molecular Weight; Polyethylene Glycols; Polymers; RNA, Small Interfering | 2010 |
Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Chitosan; Diffusion; Doxorubicin; Drug Compounding; Excipients; Galactose; Molecular Weight; Nanocapsules; Particle Size; Pharmaceutical Vehicles; Rats | 2010 |
In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Liver Neoplasms; Lymphangiogenesis; Lymphatic Metastasis; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; RNA, Messenger; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor D | 2010 |
Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Availability; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Curcumin; Drug Carriers; Enbucrilate; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; Transplantation, Heterologous | 2010 |
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB.
Topics: Animals; Becaplermin; Biocompatible Materials; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Excipients; Heparin; Humans; Hyaluronic Acid; Ischemia; Nanoparticles; Neovascularization, Physiologic; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Serum Albumin, Bovine; Tissue Engineering; Transplants; Vascular Endothelial Growth Factor A | 2010 |
Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting.
Topics: Acrylamides; Acrylic Resins; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Chitosan; Diterpenes, Kaurane; Drug Carriers; Drug Delivery Systems; Gels; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanoparticles; Polymers; Spectroscopy, Fourier Transform Infrared | 2011 |
Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
Topics: Acrylamides; Carcinoma, Hepatocellular; Chitosan; Diterpenes, Kaurane; Drug Carriers; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanogels; Polyethylene Glycols; Polyethyleneimine | 2011 |
RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; HeLa Cells; Humans; Integrins; Liver Neoplasms; Micelles; Oligopeptides; Polymers; Tumor Cells, Cultured | 2011 |
N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Chitosan; Drug Delivery Systems; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice; Nanoparticles | 2012 |
Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Female; Glycyrrhizic Acid; Humans; Liver; Liver Neoplasms; Mice; Nanoparticles; Paclitaxel; Particle Size; Rhodamines; Spectroscopy, Fourier Transform Infrared; Static Electricity; Subcellular Fractions; Tissue Distribution; Treatment Outcome; Tumor Burden | 2012 |
Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; DNA; Female; Fluorescein-5-isothiocyanate; Genetic Vectors; Humans; Interleukin-12; Liver Neoplasms; Mice; Mice, Inbred ICR; Oligopeptides; Particle Size; Polyethyleneimine; Survival Analysis; Transfection; Xenograft Model Antitumor Assays | 2012 |
Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Fluorouracil; Liver Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles | 2012 |
Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Oligopeptides; Polyethylene Glycols; Rats; Stearic Acids | 2012 |
Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.
Topics: Analysis of Variance; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; DNA Primers; Electrophoretic Mobility Shift Assay; Female; Gene Transfer Techniques; Liver Neoplasms; Mice; Mice, Inbred ICR; Microscopy, Fluorescence; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2012 |
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Cytotoxicity, Immunologic; Delayed-Action Preparations; Drug Carriers; Female; Fluorouracil; Killer Cells, Natural; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; T-Lymphocytes, Cytotoxic; Time Factors; Tumor Burden | 2012 |
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Topics: Absorption; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitin; Chitosan; DNA; Drug Carriers; Drug Delivery Systems; Drug Evaluation; Drug Stability; Galactose; Gene Targeting; Genetic Therapy; HeLa Cells; Humans; Liver Neoplasms; Nanotubes; Particle Size; Solubility; Transfection; Water | 2004 |
The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Coated Materials, Biocompatible; Drug Delivery Systems; Emulsions; Gene Transfer Techniques; Humans; Male; Materials Testing; Mice; Mice, Inbred BALB C; Particle Size; Plasmids; Solubility; Transfection | 2005 |
A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chitosan; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles.
Topics: Animals; Carcinoma, Hepatocellular; Cell Survival; Chitosan; DNA Degradation, Necrotic; DNA Fragmentation; Fatty Acids; Humans; Lipid Peroxidation; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Nanoparticles; Random Allocation; Reactive Oxygen Species; Tumor Cells, Cultured; Ultrasonography | 2007 |
Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Topics: Administration, Oral; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; DNA; Drug Carriers; Drug Delivery Systems; Gastric Mucosa; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Intestinal Absorption; Intestinal Mucosa; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Plasmids; Transfection | 2007 |
C3A cell behaviors on micropatterned chitosan collagen gelatin membranes.
Topics: Absorbable Implants; Carcinoma, Hepatocellular; Cell Adhesion; Cell Communication; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Collagen; Extracellular Matrix; Gelatin; Graft Survival; Guided Tissue Regeneration; Humans; Materials Testing; Membranes, Artificial; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Surface Properties; Tissue Engineering; Tissue Scaffolds; Tissue Transplantation | 2007 |
In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Chlorocebus aethiops; COS Cells; DNA; Drug Carriers; Galactose; HeLa Cells; Humans; Liver Neoplasms; Transfection | 2007 |
[Preparation and characterization of biotinylated chitosan nanoparticles].
Topics: Biotin; Biotinylation; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Liver Neoplasms; Nanoparticles; Particle Size; Succinimides | 2007 |
Inhibition of DNA adduct formation and mutagenic action of 3-amino-1-methyl-5h-pyrido[4,3-b]indole by chlorophyllin-chitosan in rpsL transgenic mice.
Topics: Animals; Carbolines; Carcinoma, Hepatocellular; Chitin; Chitosan; Chlorophyllides; Chromatography, Thin Layer; Diet; DNA Adducts; Dose-Response Relationship, Drug; Drug Combinations; Escherichia coli Proteins; Gene Frequency; Liver Neoplasms; Mice; Mice, Transgenic; Mutagenesis; Mutagenicity Tests; Mutagens; Ribosomal Protein S9; Ribosomal Proteins | 2001 |